ArticleOncogene2025
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.
Zheng Wu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it